Biological technologies office switch program
Other Transaction IDV Awarded Last action
- Contract number
- HR00112590062
- Awardee
-
Circe Bioscience Inc. UEI C7AVB612UH28
- Awarding agency
-
Defense Advanced Research Projects Agency
Department of Defense
- Task orders
- 0
Award facts
- Last date to order
- Not on record
- IDV ceiling
- $291,996.00
- Contracting staff
- NAICS code
- Not on record
- Set-aside
- No set-aside
- Competition
- Competed Program Solicitation
- Pricing
- Other
Award details come from SAM.gov/FPDS.
About this IDV
This Other Transaction (OT) Indefinite Delivery Vehicle (IDV) was awarded by the Defense Advanced Research Projects Agency (DARPA), a defense agency, to Circe Bioscience Inc., a for-profit manufacturer, on January 21, 2025. The $291,996.00 ceiling value IDV is for DARPA's Biological Technologies Office SWITCH program, which aims to develop advanced biotechnology capabilities. As an OT IDV, this contract mechanism allows DARPA flexibility outside the traditional Federal Acquisition Regulation (FAR)-based procurement process. The IDV does not have any set-asides. Circe Bioscience Inc., located in Somerville, MA, has been awarded previous federal contracts and grants. The period of performance and specific task orders or price lists were not provided in the information given.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Original award | $291,996 |
Quick answers
Who was awarded contract HR00112590062?
HR00112590062 was awarded to Circe Bioscience Inc. by Defense Advanced Research Projects Agency (Department of Defense) on January 21, 2025.
How much is contract HR00112590062 worth?
HR00112590062's own ceiling is $291,996.
Was contract HR00112590062 competed?
The extent of competition for HR00112590062 was competed.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV